
The number of zzso infections is zzso particularly in patients with cancer, and represent a major problem given the relatively poor response rates, especially for zzso and the high zzso zzso therapy has become an accepted practice as delay in instituting therapy is clearly associated with increased morbidity and zzso In terms of efficacy for the management of persistent zzso zzso patients, there is no convincing evidence that conventional zzso B zzso zzso is inferior to any other zzso the zzso zzso of zzso B provide similar efficacy with lower toxicity but at a much higher zzso zzso is equivalent to zzso B, provided patients at high risk of zzso infections are zzso zzso and zzso as empirical therapies, are equivalent to conventional zzso B and zzso zzso B, zzso toxicity is definitely lower and zzso is more effective at preventing breakthrough zzso zzso 

